Unknown Author
January 23, 2026
Kirkland Advises MB2 Dental on Recapitalization with New Investor Warburg Pincus

1 min
AI-made summary
- Kirkland & Ellis represented MB2 Dental, a Charlesbank portfolio company, in securing a $525 million investment from private equity firm Warburg Pincus
- The transaction, which values MB2 Dental at over $3.5 billion, offers liquidity options to the company’s doctor partners and represents its third recapitalization in seven years
- Charlesbank will maintain its partnership with MB2 Dental, a dental partnership organization focused on supporting clinical autonomy for dentists.
Kirkland & Ellis advised MB2 Dental, a Charlesbank portfolio company, on a $525 million investment by private equity firm Warburg Pincus. The investment will provide liquidity options to the company’s doctor partners at an enterprise value in excess of $3.5 billion. This deal marks the company’s third recapitalization in the last seven years. Charlesbank will continue its longstanding partnership with the company. MB2 Dental is a first-of-its-kind dental partnership organization (DPO), which empowers dentists to preserve their profession by ensuring clinical autonomy and providing resources and support to its doctor owners. Read the transaction press release The Kirkland team included corporate lawyers Dave Gusella and Shayla Harlev; debt finance lawyers John Ilardo; capital markets lawyers Josh Korff and Leia Andrew; tax lawyers Mark Schwed and Steven Ort; and healthcare & life sciences regulatory lawyer Dennis Williams.
Article Author
Unknown Author
The Sponsor
